drugset / Trial / NCT01715519

Vilazodone for the Treatment of Posttraumatic Stress Disorder

NCT01715519

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether vilazodone is effective in the treatmen of Posttraumatic Stress Disorder (PTSD)and co-morbid mild or more depression.

Timeline

Start
2012-10
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Vilazodone Small molecule 40 mg